Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

Abstract Background The use of metformin after acute myocardial infarction (AMI) has been associated with reduced mortality in people with type 2 diabetes mellitus (T2DM). However, it is not known if it is acutely cardioprotective in patients taking metformin at the time of AMI. We compared patient...

Full description

Bibliographic Details
Main Authors: Daniel I. Bromage, Tom R. Godec, Mar Pujades-Rodriguez, Arturo Gonzalez-Izquierdo, S. Denaxas, Harry Hemingway, Derek M. Yellon
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cardiovascular Diabetology
Subjects:
Acute myocardial infarction
Cardioprotection
Cohort studies
Metformin
Outcomes
Type 2 diabetes
Online Access:https://doi.org/10.1186/s12933-019-0972-4

Internet

https://doi.org/10.1186/s12933-019-0972-4

Similar Items